Glaucoma Surgery Market Trends is anticipated to mask a remarkable CAGR during the forecast period
Market Overview:
Glaucoma is an eye
disorder that causes damage to the optic
nerve if left untreated, leading to the permanent loss of vision. As per the
report that has been published by Market research Future (MRFR), the global
glaucoma surgery market is registered to expand at a noteworthy CAGR of 7.9%
during the forecast period of 2017-2023.
https://www.marketresearchfuture.com/sample_request/1342
Glaucoma
is considered to be one of the leading causes of preventable blindness. With the rise in geriatric population, the
incidences of glaucoma are increasing resulting in the high demand for surgical
treatments, which in turn is fueling the growth of the global glaucoma surgery
market. Increasing inclination towards permanent and faster cure through
surgery over long-term use of medication
is one of the major drivers of the global glaucoma surgery market. In addition,
rise in prevalence of causative disorders
such as diabetes and ocular hypertension are inducing need for surgical treatments, leading to the expansion of the
global glaucoma surgery market. However,
lack of awareness, preference of non-invasive treatments and high cost
associated with the treatment are likely to create hindrance in the growth of
the global glaucoma surgery market during the forecast period.
The global Glaucoma Surgery Market Trends has been segmented on the basis of target, surgery and end-user. Based on target, the glaucoma surgery market is segmented into trabecular
meshwork, suprachoroidal space and
others. Based on surgery, the glaucoma surgery market is segmented into angle
closure glaucoma surgery, aqueous shunt surgery, laser surgery and others.
Based on end users, the glaucoma surgery market is segmented into hospital, ambulatory surgery centers and others.
The global glaucoma
surgery market is geographically segmented into four major regions such as
North America, Asia Pacific, Europe and the Middle East and Africa. The North America region is leading the global
glaucoma surgery market with respect to market size. The high number of
population suffering from diabetes and other eye disorder and increasing
healthcare expenditure are some of the major factors that are fueling the
growth of the glaucoma surgery market in this region. The Europe region is
registered to be the second largest market for glaucoma surgery owing to the increased
research and development for introduction
of advanced surgical devices in this region. The Asia Pacific region is
projecting significant growth in the global glaucoma surgery market owing to
the large population base and increasing prevalence of glaucoma in this region.
The leading players profiled by MRFR in the report
on the global glaucoma surgery market are Novartis AG (Switzerland), Allergan
(the U.S.), Merck & Co., Inc. (the U.S.), Abbott (the U.S.), Akorn, Inc.
(the U.S.), Teva Pharmaceuticals (the U.S.), Bausch & Lomb (the U.S.),
Pfizer, Santen (Japan), Carl Zeiss Meditec (Germany), Alcon (the U.S.),
Ellex Medical Lasers (Australia), Lumenis (the U.S.), Topcon Medical Systems
(the U.S.), Nidek (the U.S.), OPHTEC (the U.S.), Optos (the U.S.), Accutome
(the U.S.), AqueSys (Taiwan), Canon (Japan), Essilor (France) and Iridex Corporation (the U.S.)
https://www.marketresearchfuture.com/reports/glaucoma-surgery-market-1342
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment